Held on 28 March 2014
Lyka Labs has announced the Board of Directors of the Company at its meeting held on 28 March 2014, has decided the following :To re-appoint N I Gandhi as Managing Director for a period of 5 years with effect from 01 April 2014 subject to approval of Shareholders in the General Meeting and other Statutory Approvals.
To invest in 35,00,000 equity shares of Rs 10 each of Lyka Exports at a premium of Rs 25 in lieu of its outstanding subject to approval of the shareholders in the General Meeting.
3. To transfer domestic marketing division of Ethical products under slump sale to Lyka Healthcare, a wholly owned subsidiary Company with effect from 01 March 2014.
Powered by Capital Market - Live News
